Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 1-Year High – Still a Buy?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $9.91 and last traded at $9.89, with a volume of 31150 shares trading hands. The stock had previously closed at $9.72.

Wall Street Analysts Forecast Growth

Separately, Citigroup raised shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a research report on Friday, October 25th.

Fresenius SE & Co. KGaA Stock Up 1.8 %

The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. The firm’s fifty day moving average price is $9.13 and its two-hundred day moving average price is $9.10.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.